Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005; 92:1862-8....
However, the only risk factors for intrahepatic recurrence were portal vein invasion and hepatitis C virus (HCV) infection. The former was related to early recurrence while the latter was related to later recurrence. The 5-year disease-free survival rate was 58 per cent in patients with ...
Prediction of Overall Survival Rate in Patients With Hepatocellular Carcinoma Using an Integrated Model Based on Autophagy Gene Marker 来自 EBSCO 喜欢 0 阅读量: 102 作者:S Wang,D Yang,W Kong 摘要: The autophagy cell, which can inhibit the formation of tumor in the early stage and can promote...
PURPOSE The invasion of the portal and hepatic veins in hepatocellular carcinoma (HCC) has been well documented, but the reports concerning biliary tumor thrombi in patients with HCC are very rare because of the low rate of occurrence. We report on our clinical experiences and evaluate the clini...
To analyze survival and its predictors among patients with hepatocellular carcinoma (HCC) receiving transarterial chemoembolization (TACE) in Ethiopia.#We conducted a retrospective cohort study among patients who received TACE for HCC at MCM Hospital from December 1, 2016, to December 31, 2022. Data...
Other risk factors for liver cancer may include: Yoursex.Men are more likely to get hepatocellular carcinoma than women. and liver cancer. This is likely due to the link between diabetes and fatty liver disease.
the incidence for liver cancer has been rising each year over the last 10 years in the US and worldwide, while the five-year survival remains at a dismal rate of ~18%32,33. The vast majority (~90%) of liver cancers are HCC. Although the risk factors for HCC are well known—includin...
elucidate geographic differences and time trends for these variables.Since comparisons based on cancer registry data are problematic because of variations in liver cancer definition and coding, we considered a subset of cases likely to be mainly hepatocellular carcinoma, suitable for international ...
Liver transplantation (OLT) is the treatment of choice for patients with hepatic cirrhosis related hepatocellular carcinoma (HCC). Among 156 liver transpla... JW Park,KW Lee,SJ Kim,... - 《Transplantation Proceedings》 被引量: 54发表: 2006年 Rate of Tumor Growth Predicts Recurrence of Hepatoce...
600#Background:Immunotherapy combinations such as atezolizumab plus bevacizumab (Atezo-Bev) or STRIDE have been established as standard therapies for patients with advanced hepatocellular carcinoma (HCC). After dual immunotherapy treatment, durable responders and long-term survivors had been reported. ...